|
Index of reports
> Cases with Pneumonia (108)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 108 Next >>
Possible Cytarabine side effects in 44 year old male
Reported by a physician from Germany on 2012-08-17
Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-12
Etoposide
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-08
Gemtuzumab Ozogamicin
Dosage: 6 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-08
End date: 2012-06-08
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-10
End date: 2012-06-10
Idarubicin HCL
Dosage: 24 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Tretinoin
Dosage: 90 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-11
End date: 2012-06-12
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-13
End date: 2012-06-16
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-21
End date: 2012-06-21
Possible Cytarabine side effects in 50 year old male
Reported by a physician from Germany on 2012-08-16
Patient: 50 year old male, weighing 73.0 kg (160.6 pounds)
Reactions: Neutropenic Colitis, Pneumonia
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 90 mg, unk
Start date: 2012-07-25
Cytarabine
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Etoposide
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-21
Idarubicin HCL
Dosage: 22.56 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-14
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Pulmonary Haemorrhage, White Blood Cell Count Decreased, Pneumonia, Hypotonia, Stenotrophomonas Infection, Blood Pressure Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 25 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-18
End date: 2012-06-22
Cytarabine
Dosage: 750 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-18
End date: 2012-06-22
Idarubicin HCL
Dosage: 12 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-18
End date: 2012-06-20
Other drugs received by patient: Noxafil; Ambisome; Aciclovir-Ratiopharm; Clindamycin; Pantoprazole; Zienam; Piperacillin W
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-09
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-06-15
Daunorubicin HCL
Start date: 2012-06-15
Revlimid
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-29
Other drugs received by patient: Ciprofloxacin HCL; Temazepam; Lisinopril; Fluconazole; Colistin
Possible Cytarabine side effects in 50 year old male
Reported by a physician from Germany on 2012-08-07
Patient: 50 year old male
Reactions: Neutropenic Colitis, Pneumonia
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 90 mg, unk
Start date: 2012-07-25
Cytarabine
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Etoposide
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-21
Idarubicin HCL
Dosage: 22.56 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Possible Cytarabine side effects in 50 year old male
Reported by a physician from Germany on 2012-08-02
Patient: 50 year old male
Reactions: Neutropenic Colitis, Pneumonia
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 90 mg, unk
Start date: 2012-07-25
Cytarabine
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Etoposide
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-21
Idarubicin HCL
Dosage: 22.56 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-07-30
Patient: male, weighing 60.0 kg (132.0 pounds)
Reactions: Pneumonia, Intervertebral Discitis, Febrile Bone Marrow Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Mantle Cell Lymphoma
Start date: 2012-02-15
End date: 2012-04-22
Cytarabine
Indication: Mantle Cell Lymphoma
Start date: 2012-02-15
End date: 2012-04-22
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-15
End date: 2012-04-22
Mabthera
Indication: Mantle Cell Lymphoma
Start date: 2012-02-15
End date: 2012-04-22
Other drugs received by patient: Clopidogrel
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-07-30
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-06-15
Daunorubicin HCL
Start date: 2012-06-15
Revlimid
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-29
Other drugs received by patient: Fluconazole; Ciprofloxacin HCL; Temazepam; Lisinopril; Colistin
Possible Cytarabine side effects in female
Reported by a physician from France on 2012-07-25
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Pneumonia, Bone Marrow Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 184 mg/cycle on 03/apr/2012
Indication: Mantle Cell Lymphoma
Start date: 2012-04-03
Cytarabine
Dosage: 7.4 g/cycle between 03/apr/2012 and 04/apr/2012
Indication: Mantle Cell Lymphoma
Start date: 2012-04-03
Mabthera
Dosage: 700 mg/cycle on 05/apr/2012 (normally on d4= 06/apr/2012 for cycle 1)
Indication: Mantle Cell Lymphoma
Start date: 2012-04-05
Other drugs received by patient: Eprex; Innohep
Possible Cytarabine side effects in 66 year old male
Reported by a physician from Japan on 2012-07-20
Patient: 66 year old male
Reactions: Pneumonia, Interstitial Lung Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 40 mg/m2, unk
Start date: 2010-12-22
End date: 2010-12-22
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-10-14
End date: 2010-10-14
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-11-24
End date: 2010-11-24
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-12-29
End date: 2010-12-29
Adriamycin PFS
Dosage: 40 mg/m2, unk
Start date: 2010-11-16
End date: 2010-11-16
Adriamycin PFS
Dosage: 40 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-10-07
Allopurinol
Dosage: 100 mg, 3x/day
Administration route: Oral
Start date: 2011-07-05
End date: 2011-07-19
Allopurinol
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Hyperuricaemia
End date: 2011-01-20
Amlodipine
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2010-10-08
End date: 2011-02-17
Baraclude
Dosage: 0.5 mg, 1/2day
Administration route: Oral
Indication: Hepatitis B
Start date: 2010-06-29
End date: 2011-07-19
Carboplatin
Dosage: 250 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
Cefazolin Sodium
Dosage: unk
Administration route: Oral
Indication: Proctitis
Start date: 2010-10-22
End date: 2011-02-17
Cyclophosphamide
Dosage: 350 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-22
Cymerin
Dosage: 60 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-14
End date: 2010-12-29
Cytarabine
Dosage: 40 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Diflucan
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Antifungal Prophylaxis
End date: 2011-01-11
Diflucan
Dosage: unk
Start date: 2011-01-19
End date: 2011-01-28
Etoposide
Dosage: 100 mg/m2, 3x/day
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
Fentanyl
Dosage: unk
Indication: Stomatitis
Start date: 2011-01-02
End date: 2011-01-19
Fildesin
Dosage: 2.4 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
KW-0761
Dosage: 1 mg/kg, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-08
End date: 2010-12-21
Lansoprazole
Dosage: 15 mg, 1x/day
Administration route: Oral
Start date: 2011-05-26
End date: 2011-07-19
Lansoprazole
Dosage: 15 mg, 1x/day
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
End date: 2011-02-17
Lipidil
Dosage: 100 df, 1x/day
Administration route: Oral
Indication: Hyperlipidaemia
End date: 2011-01-26
Lyrica
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Pain
Start date: 2011-06-29
End date: 2011-07-19
Magmitt
Dosage: unk
Administration route: Oral
Indication: Constipation
Start date: 2011-01-07
End date: 2011-01-10
Meropenem
Dosage: 0.5 g, 2x/day
Indication: Pneumonia
Start date: 2011-01-07
End date: 2011-01-24
Meropenem
Dosage: 1 g, 3x/day
Start date: 2011-07-04
End date: 2011-07-15
Methotrexate Sodium
Dosage: 15 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Oncovin
Dosage: 1 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-22
Pantosin
Dosage: unk
Administration route: Oral
Indication: Constipation
Start date: 2011-01-07
End date: 2011-01-10
Prednisolone
Dosage: 40 mg/m2, unk
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-29
Prednisolone
Dosage: 10 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Sulfamethoxazole and Trimethoprim
Dosage: 1 df, 1x/day
Administration route: Oral
Start date: 2011-07-15
Sulfamethoxazole and Trimethoprim
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Antifungal Prophylaxis
End date: 2011-01-28
Vancomycin
Dosage: 0.5 g, 2x/day
Start date: 2011-01-07
End date: 2011-01-17
Zovirax
Dosage: unk
Start date: 2011-06-30
End date: 2011-07-08
Zovirax
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Prophylaxis
End date: 2011-01-28
Zovirax
Dosage: 200 mg, 1x/day
Administration route: Oral
Start date: 2011-07-12
End date: 2011-07-19
Other drugs received by patient: Vfend; Targocid; Slow-K; Ciprofloxacin HCL
Possible Cytarabine side effects in 44 year old male
Reported by a physician from Germany on 2012-07-19
Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-12
Etoposide
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-08
Gemtuzumab Ozogamicin
Dosage: 6 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-08
End date: 2012-06-08
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-10
End date: 2012-06-10
Idarubicin HCL
Dosage: 24 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Tretinoin
Dosage: 90 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-11
End date: 2012-06-12
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-13
End date: 2012-06-16
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-21
End date: 2012-06-21
Possible Cytarabine side effects in
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient:
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carmustine
Dosage: day - 7
Cytarabine
Dosage: day -6 til day -3
Etoposide
Dosage: day -6 till day -3
Melphalan Hydrochloride
Dosage: day -2
Rituxan
Dosage: day - 19 and day - 12
Velcade
Dosage: d2 and d8
Indication: non-Hodgkin's Lymphoma
Start date: 2012-05-01
Vorinostat
Dosage: 200 mg, qd
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-30
End date: 2012-05-06
Other drugs received by patient: Zovirax; Diphenhydramine HCL; Loperamide HCL; Dapsone; Compazine; Cholecalciferol; Allegra; Citalopram Hydrobromide; Bactrim; Potassium Chloride; Vitamin D (Unspecified); Potassium Bicarbonate; Nystatin; Lorazepam; Zofran; Folic Acid; Vitamins (Unspecified)
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-17
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Pneumonia, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
End date: 2012-05-12
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-11
Cytarabine
Dosage: 3800 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-12
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin
Possible Cytarabine side effects in 55 year old male
Reported by a physician from Austria on 2012-07-17
Patient: 55 year old male, weighing 77.0 kg (169.4 pounds)
Reactions: Pneumonia, Colitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 90 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-04
End date: 2012-06-06
Atracurium Besylate
Dosage: 30 mg, 1x/day
Start date: 2012-06-07
Cytarabine
Dosage: 194 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-30
End date: 2012-06-05
Etoposide
Dosage: 190 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-30
End date: 2012-06-01
Idarubicin HCL
Dosage: 23 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-30
End date: 2012-06-03
Other drugs received by patient: Vfend; Pantoprazole; Allopurinol; Meropenem
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-07-06
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia, Leukoencephalopathy
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cellcept
Dosage: last dose prior to sae: 24/mar/2012
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-10
Cisplatin
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Cyclosporine
Dosage: last dose prior to sae: 24/mar/2012
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-08
Cytarabine
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-17
Dexamethasone
Dosage: last dose prior to sae: 19/dec/2011
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Fludarabine Phosphate
Dosage: date of last dose prior to sae: 08/feb/2012
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-06
Mabthera
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Other drugs received by patient: Valacyclovir Hydrochloride; Anti-Thymocyte Globulin NOS; Cotrim; Prednisolone; Mitoxantrone; Prednisolone; Voriconazole; Posaconazole; Cotrim
Possible Cytarabine side effects in 44 year old male
Reported by a physician from Germany on 2012-07-06
Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-12
Etoposide
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-08
Gemtuzumab Ozogamicin
Dosage: 6 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Idarubicin HCL
Dosage: 24 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-08
End date: 2012-06-08
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-10
End date: 2012-06-10
Tretinoin
Dosage: 90 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-11
End date: 2012-06-12
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-21
End date: 2012-06-21
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-13
End date: 2012-06-16
Possible Cytarabine side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-04
Patient: 59 year old male
Reactions: Viral Infection, Pneumonia, Respiratory Failure, Acute Myeloid Leukaemia, Neutropenic Sepsis, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: continuous iv infusion for 7 days
Idarubicin HCL
Dosage: 12 mg/m2/day for three days
Methylprednisolone
Indication: Immunosuppression
Mycophenolate Mofetil
Indication: Immunosuppression
Sirolimus
Tacrolimus
Indication: Immunosuppression
Possible Cytarabine side effects in 55 year old male
Reported by a physician from Austria on 2012-07-02
Patient: 55 year old male, weighing 77.0 kg (169.4 pounds)
Reactions: Pneumonia, Colitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 30 mg, 1x/day
Start date: 2012-06-07
Atracurium Besylate
Dosage: 90 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-04
End date: 2012-06-06
Cytarabine
Dosage: 194 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-30
End date: 2012-06-05
Etoposide
Dosage: 190 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-30
End date: 2012-06-01
Idarubicin HCL
Dosage: 23 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-30
End date: 2012-06-03
Other drugs received by patient: Meropenem; Allopurinol; Vfend; Pantoprazole
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-02
Patient: male, weighing 98.5 kg (216.7 pounds)
Reactions: Pneumonia, Pyrexia, Neutropenia, Legionella Infection, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Possible Cytarabine side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-22
Patient: female, weighing 65.2 kg (143.4 pounds)
Reactions: Pneumonia, Febrile Neutropenia, Bone Marrow Failure, Escherichia Bacteraemia, Aspergillus Test Positive, Hydropneumothorax
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 40800 mg
Elspar
Dosage: 20000 mg
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-06-19
Patient: female, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia, Respiratory Failure, Influenza
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
End date: 2012-05-12
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-12
Evoltra
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-11
Other drugs received by patient: Amphotericin B; Vancomycin; Meropenem
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-06-13
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia, Leukoencephalopathy
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cellcept
Dosage: last dose prior to sae: 24/mar/2012
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-10
Cisplatin
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Cyclosporine
Dosage: last dose prior to sae: 24/mar/2012
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-08
Cytarabine
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-17
Dexamethasone
Dosage: last dose prior to sae: 19/dec/2011
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Fludarabine Phosphate
Dosage: date of last dose prior to sae: 08/feb/2012
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-06
Mabthera
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Other drugs received by patient: Posaconazole; Voriconazole; Valacyclovir Hydrochloride; Cotrim; Cotrim
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13
Patient: male
Reactions: Pneumonia, Interstitial Lung Disease, Hypotension, Chills, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Lymphoma
Start date: 2010-09-03
End date: 2010-09-03
Cytarabine
Indication: Lymphoma
Start date: 2010-09-03
Etoposide
Indication: Lymphoma
Start date: 2010-09-03
End date: 2010-09-05
Gemcitabine Hydrochloride
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Gemcitabine Hydrochloride
Start date: 2010-11-11
End date: 2010-11-14
Ifosfamide
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Ifosfamide
Start date: 2010-11-11
End date: 2010-11-14
Mabthera
Start date: 2010-05-07
End date: 2010-11-10
Mabthera
Dosage: vial 500 mg/50 ml
Indication: Lymphoma
Start date: 2010-05-07
End date: 2010-10-05
Mabthera
Dosage: vial 500 mg 50 ml
End date: 2010-10-15
Methylprednisolone
Start date: 2010-11-11
End date: 2010-11-14
Methylprednisolone
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Vinorelbine
Indication: Lymphoma
Start date: 2010-10-19
End date: 2010-10-20
Vinorelbine
Start date: 2010-11-11
End date: 2010-11-14
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-06-12
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Pneumonia, Respiratory Failure, Influenza
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
End date: 2012-05-12
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-11
Cytarabine
Dosage: 3800 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-12
Other drugs received by patient: Vancomycin HCL; Meropenem; Amphotericin B
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-06-12
Patient: male, weighing 109.0 kg (239.8 pounds)
Reactions: Mucosal Inflammation, Pneumonia, Febrile Neutropenia, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Necrotising Fasciitis, Septic Shock, Full Blood Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
Daunorubicin HCL
Dosage: 70 mg
Methotrexate
Dosage: 15 mg
Methylprednisolone
Dosage: 70 mg
PEG-L-Asparaginase (K-H)
Dosage: 5500 mg
Vincristine Sulfate
Dosage: 8 mg
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-06-06
Patient: female, weighing 21.4 kg (47.1 pounds)
Reactions: Pneumonia, Cardiac Murmur, Tachycardia, Pancytopenia, Endocarditis, Tricuspid Valve Incompetence, Staphylococcal Bacteraemia, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 30 mg
End date: 2012-04-23
Mitoxantrone Hydrochloride
Dosage: 16.4 mg
End date: 2012-04-26
Tretinoin
Dosage: 280 mg
End date: 2012-05-07
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from Netherlands on 2012-06-01
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia, Leukoencephalopathy
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cellcept
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-10
Cisplatin
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Cyclosporine
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-08
Cytarabine
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-17
Dexamethasone
Dosage: last dose prior to sae 19/dec/2011
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Fludarabine Phosphate
Dosage: date of last dose prior to sae: 08/feb/2012
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2012-02-06
Mabthera
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-16
Other drugs received by patient: Posaconazole; Cotrim; Valacyclovir Hydrochloride; Cotrim; Voriconazole
Possible Cytarabine side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30
Patient: 49 year old female
Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 100 mg
Administration route: Oral
Indication: Anaemia
Cyclophosphamide
Indication: Breast Cancer
Cyclophosphamide
Indication: Leukocytosis
Start date: 2009-07-01
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Prednisolone
Indication: Leukocytosis
Prednisolone
Dosage: 15 mg
Indication: Anaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Possible Cytarabine side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-28
Patient: 49 year old female
Reactions: Pneumonia, B Precursor Type Acute Leukaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Cytarabine
Indication: Breast Cancer
Dexamethasone
Indication: Breast Cancer
Doxorubicin HCL
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Methotrexate
Indication: Breast Cancer
Vincristine
Indication: Breast Cancer
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-05-24
Patient: female, weighing 21.4 kg (47.1 pounds)
Reactions: Streptococcal Bacteraemia, Pneumonia, Tachycardia, Pancytopenia, Endocarditis, Tricuspid Valve Incompetence, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 30 mg
End date: 2012-04-23
Mitoxantrone Hydrochloride
Dosage: 16.4 mg
End date: 2012-04-26
Tretinoin
Dosage: 280 mg
End date: 2012-05-07
Page 1 Next >>
|
